Millennium Management’s Agios Pharmaceuticals AGIO Stock Holding History

Millennium Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-15,000	Closed	-$421K	–	6306
2022 Q4	$421K	Buy	+15,000	New	+$423K	﹤0.01%	4862
2021 Q2	–	Sell	-15,000	Closed	-$775K	–	6462
2021 Q1	$775K	Buy	+15,000	New	+$743K	﹤0.01%	4448
2020 Q3	–	Sell	-85,000	Closed	-$4.55M	–	4395
2020 Q2	$4.55M	Buy	+85,000	New	+$3.94M	0.01%	1858
2019 Q4	–	Sell	-75,000	Closed	-$2.43M	–	4155
2019 Q3	$2.43M	Sell	75,000 -25,000	-25%	-$1.03M	﹤0.01%	2329
2019 Q2	$4.99M	Buy	+100,000	New	+$5.34M	0.01%	1793

Other funds holding AGIO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

EAM

Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Millennium Management's AGIO Position: Q1 2026 in Review

Millennium Management reduced its Agios Pharmaceuticals (AGIO) stake by 92% in Q1 2026, selling an estimated $10.4M and leaving 32,144 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #4328.

Millennium Management first reported a position in AGIO in Q1 2014 and has held it in 37 quarters since. The position peaked at $35.2M in Q1 2016. 232 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

Millennium Management held 32,144 shares of Agios Pharmaceuticals worth $1.09M as of Q1 2026.
Millennium Management sold 366,123 Agios Pharmaceuticals shares in Q1 2026, an estimated $10.4M.
Agios Pharmaceuticals made up ﹤0.01% of Millennium Management's portfolio in Q1 2026, its #4328 holding.
Millennium Management first reported a position in Agios Pharmaceuticals in Q1 2014 and has held it in 37 quarters since.
Millennium Management's Agios Pharmaceuticals position peaked at $35.2M in Q1 2016.
232 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.